← Leaderboards
Jeremiah Allen Johnson
Massachusetts Institute Of Technology
$5,112,849
Attributed
$5,112,849
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $982.1K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,112,849 · 3
By mechanism
R01$4,334,490 · 1
R21$778,359 · 2
Top collaborators
No co-investigators on record.
Most similar at Massachusetts Institute Of Technology
Same institution · by research overlap
- Peter Karl Sorger$53,861,857
- Michael Hemann$6,314,382
- Robert S Langer$47,407,448
- Jacqueline A. Lees$17,361,359
- Christian T Farrar$64,203
Others in their field
Top investigators on “Drug Kinetics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$241,865,009
- Sharon A Nachman · Johns Hopkins University$194,646,762
- Carol Nesel · Westat$147,274,423
- Barbara Driver · Westat, Inc.$103,746,400
- Ronald T Mitsuyasu · University Of California Los Angeles$99,239,507
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,714,869
Research focus
Drug KineticsIn VitroCytotoxicityTumorBiodistributionResistanceContrast MediaToxic EffectMagnetic Resonance ImagingIn VivoDrug Delivery SystemsPharmaceutical PreparationsAffinityTechnologyAntibodiesPolymersTreatment EfficacyBindingImage GuidedReporterReportingResponseMucin 1 ProteinCancer Cell
Grant awards (11)
Bottlebrush polymer prodrugs for targeted delivery of combination therapies and in vivo imaging of pharmacological response$595,926
R01 · FY2025 · CA · contact PI
Molecular Tailoring of Bispecific AntibodyâBottlebrushConjugates$386,194
R21 · FY2025 · AI · contact PI
Bottlebrush polymer prodrugs for targeted delivery of combination therapies and in vivo imaging of pharmacological response$566,131
R01 · FY2024 · CA · contact PI
Bottlebrush polymer prodrugs for targeted delivery of combination therapies and in vivo imaging of pharmacological response$610,792
R01 · FY2023 · CA · contact PI
Organic nanoparticles for dual MRI-guided therapeutic selection and ovarian cancer drug delivery$509,485
R01 · FY2021 · CA · contact PI
Organic nanoparticles for dual MRI-guided therapeutic selection and ovarian cancer drug delivery$509,485
R01 · FY2020 · CA · contact PI
Organic nanoparticles for dual MRI-guided therapeutic selection and ovarian cancer drug delivery$494,201
R01 · FY2019 · CA · contact PI
Organic nanoparticles for dual MRI-guided therapeutic selection and ovarian cancer drug delivery$509,485
R01 · FY2018 · CA · contact PI
Organic nanoparticles for dual MRI-guided therapeutic selection and ovarian cancer drug delivery$538,985
R01 · FY2017 · CA · contact PI
PEG-Branch-Nitroxide Nanostructured Organic MRI Contrast Agents$206,901
R21 · FY2015 · EB · contact PI
PEG-Branch-Nitroxide Nanostructured Organic MRI Contrast Agents$185,264
R21 · FY2014 · EB · contact PI